Insys to file NDA for synthetic cannabinoid solution this quarter

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Insys Therapeutics (INSY) plans to file an NDA this quarter for Dronabinol Oral Solution for the treatment of chemotherapy-induced nausea and vomiting and for the treatment of anorexia in patients with AIDS.

Dronabinol is currently off patent and available in a soft gelatin capsule form. The oral solution has a faster onset of action and will enable physicians to titrate patients more precisely.